Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2407

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma ; volume:19 ; number:1 ; day:7 ; month:8 ; year:2019 ; pages:1-9 ; date:12.2019
BMC cancer ; 19, Heft 1 (7.8.2019), 1-9, 12.2019

Creator: Doma, V.
Kárpáti, S.
Rásó, E.
Barbai, T.
Tímár, J.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12885-019-5990-9

URN: urn:nbn:de:101:1-2020011119593764161851

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:00 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Doma, V.
Kárpáti, S.
Rásó, E.
Barbai, T.
Tímár, J.
SpringerLink (Online service)

Other Objects (12)

$Correction to: Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma$

Correction to: Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma

Hochschulschrift

BRAF- und NRAS-Mutationen in Melanomen von Patienten mit Mehrfachmelanomen

Variation of mutant allele frequency in NRAS Q61 mutated melanomas

Variations of BRAF mutant allele percentage in melanomas

Zirkulierende Tumor DNA erlaubt Therapiemonitoring in BRAF und NRAS mutiertem malignem Melanom

Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma

Hochschulschrift

Die kombinierte MEK- und BRAF-Inhibierung als neuer Therapieansatz beim NRAS-mutierten Melanom

NRAS Q61R , BRAF V600E immunohistochemistry: a concomitant tool for mutation screening in melanomas

Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma

Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care

$Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas$

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

BRAF activation by metabolic stress promotes glycolysis sensitizing NRAS Q61 -mutated melanomas to targeted therapy

$Correction to: Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma$

Correction to: Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma

Hochschulschrift

BRAF- und NRAS-Mutationen in Melanomen von Patienten mit Mehrfachmelanomen

Variation of mutant allele frequency in NRAS Q61 mutated melanomas

Variations of BRAF mutant allele percentage in melanomas

Zirkulierende Tumor DNA erlaubt Therapiemonitoring in BRAF und NRAS mutiertem malignem Melanom

Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma

Hochschulschrift

Die kombinierte MEK- und BRAF-Inhibierung als neuer Therapieansatz beim NRAS-mutierten Melanom

NRAS Q61R , BRAF V600E immunohistochemistry: a concomitant tool for mutation screening in melanomas

Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma

Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care

$Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas$

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

BRAF activation by metabolic stress promotes glycolysis sensitizing NRAS Q61 -mutated melanomas to targeted therapy

$Correction to: Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma$

Correction to: Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma

Hochschulschrift

BRAF- und NRAS-Mutationen in Melanomen von Patienten mit Mehrfachmelanomen

Variation of mutant allele frequency in NRAS Q61 mutated melanomas

Variations of BRAF mutant allele percentage in melanomas

Zirkulierende Tumor DNA erlaubt Therapiemonitoring in BRAF und NRAS mutiertem malignem Melanom

Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma

Hochschulschrift

Die kombinierte MEK- und BRAF-Inhibierung als neuer Therapieansatz beim NRAS-mutierten Melanom

NRAS Q61R , BRAF V600E immunohistochemistry: a concomitant tool for mutation screening in melanomas

Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma

Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care

$Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas$

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

BRAF activation by metabolic stress promotes glycolysis sensitizing NRAS Q61 -mutated melanomas to targeted therapy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Correction to: Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma

BRAF- und NRAS-Mutationen in Melanomen von Patienten mit Mehrfachmelanomen

Variation of mutant allele frequency in NRAS Q61 mutated melanomas

Variations of BRAF mutant allele percentage in melanomas

Zirkulierende Tumor DNA erlaubt Therapiemonitoring in BRAF und NRAS mutiertem malignem Melanom

Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma

Die kombinierte MEK- und BRAF-Inhibierung als neuer Therapieansatz beim NRAS-mutierten Melanom

NRAS Q61R , BRAF V600E immunohistochemistry: a concomitant tool for mutation screening in melanomas

Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma

Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

BRAF activation by metabolic stress promotes glycolysis sensitizing NRAS Q61 -mutated melanomas to targeted therapy

Correction to: Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma

BRAF- und NRAS-Mutationen in Melanomen von Patienten mit Mehrfachmelanomen

Variation of mutant allele frequency in NRAS Q61 mutated melanomas

Variations of BRAF mutant allele percentage in melanomas

Zirkulierende Tumor DNA erlaubt Therapiemonitoring in BRAF und NRAS mutiertem malignem Melanom

Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma

Die kombinierte MEK- und BRAF-Inhibierung als neuer Therapieansatz beim NRAS-mutierten Melanom

NRAS Q61R , BRAF V600E immunohistochemistry: a concomitant tool for mutation screening in melanomas

Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma

Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

BRAF activation by metabolic stress promotes glycolysis sensitizing NRAS Q61 -mutated melanomas to targeted therapy

Correction to: Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma

BRAF- und NRAS-Mutationen in Melanomen von Patienten mit Mehrfachmelanomen

Variation of mutant allele frequency in NRAS Q61 mutated melanomas

Variations of BRAF mutant allele percentage in melanomas

Zirkulierende Tumor DNA erlaubt Therapiemonitoring in BRAF und NRAS mutiertem malignem Melanom

Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma

Die kombinierte MEK- und BRAF-Inhibierung als neuer Therapieansatz beim NRAS-mutierten Melanom

NRAS Q61R , BRAF V600E immunohistochemistry: a concomitant tool for mutation screening in melanomas

Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma

Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

BRAF activation by metabolic stress promotes glycolysis sensitizing NRAS Q61 -mutated melanomas to targeted therapy

Related objects

Reset password